Human evidence record · Epitalon
Epitalon in retinitis pigmentosa
The publication reported a positive clinical effect in approximately 90% of treated cases.
Quick read
Human evidence record
What this study tells us
This is human clinical evidence. Its strength depends on the study design, sample size, comparator, population, duration and the outcome that was actually measured.
Who was studied?
Patients with retinitis pigmentosa
How many?
n=162
What happened?
The publication reported a positive clinical effect in approximately 90% of treated cases.
What stops us overclaiming?
Older regional ophthalmic study; route and indication are highly specific and cannot support systemic longevity claims.
Need help with terms such as randomized, placebo, endpoint or sample size? Open the glossary →
Key result
The publication reported a positive clinical effect in approximately 90% of treated cases.
Study details
Study designOlder clinical study
PopulationPatients with retinitis pigmentosa
Sample size162
RouteParabulbar ophthalmic injection
Regimen / exposure5 micrograms per eye daily
Duration10 consecutive days
ComparatorHistorical clinical comparator/context
Primary endpoint / questionVisual/retinal clinical outcomes
Safety resultModern standardized adverse-event reporting was limited.
Key limitationsOlder regional ophthalmic study; route and indication are highly specific and cannot support systemic longevity claims.
Registry / identifierPMID 12195242